Condition (MeSH)
Epilepsy, Complex Partial
ClinicalTrials.gov lists 16 trials for Epilepsy, Complex Partial or a narrower condition beneath it. SK Life Science, Inc. has the most among industry and government lead sponsors, with 5.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
16 of the 16 trials are tagged with Epilepsy, Complex Partial itself; the rest are tagged with a narrower condition beneath it.
When did Epilepsy, Complex Partial trials start? (10)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2018 | 1 |
| 2017 | 1 |
| 2010 | 1 |
| 2009 | 4 |
| 2008 | 1 |
| 2007 | 2 |
| 2006 | 3 |
| 2002 | 1 |
| 2001 | 1 |
| 1994 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 16 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Epilepsy, Complex Partial trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 9 |
| Phase 4 | 2 |
| Observational | 3 |
How many Epilepsy, Complex Partial trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 15 |
| Terminated | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Epilepsy, Complex Partial trials? (8)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| SK Life Science, Inc. | 5 |
| Pfizer | 2 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2 |
| Eisai Inc. | 1 |
| Lundbeck LLC | 1 |
Showing 5 of 8 sponsors.
Which drugs are being tested for Epilepsy, Complex Partial? (4)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Carisbamate | 5 |
| Pregabalin | 4 |
| Ganaxolone | 1 |
| Vigabatrin | 1 |
Interventions as named in the registry (5)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Vanquix Auto-Injector (Diazepam Injection) | 1 |
| Low dose zonisamide | 1 |
| Levetiracetam XR | 1 |
| Gabapentin 6% | 1 |
| BIS-001 ER | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Epilepsy, Complex Partial trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| EPILEPSY | 16 | 1 |
| Convulsion | 9 | 2 |
| Epilepsy | 5 | 2 |
| Pneumonia | 5 | 3 |
| Status epilepticus | 5 | 2 |
Showing 5 of 10 adverse events.
Which publications cover Epilepsy, Complex Partial? (29)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures. | Neurology | 2012 | Yes |
| Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy. | Epilepsia | 2009 | Yes |
| A comparison of the circadian rhythms and the levels of melatonin in patients with diurnal and nocturnal complex partial seizures. | Epilepsy & behavior : E&B | 2006 | Yes |
| SPECT perfusion changes during complex partial seizures in patients with hippocampal sclerosis. | Brain : a journal of neurology | 2003 | Yes |
| Practice parameter: temporal lobe and localized neocortical resections for epilepsy. | Epilepsia | 2003 | Yes |
Showing 5 of 29 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.